PDPK1 and hepatocellular carcinoma: Furthermore, Kaplan-Meier analysis showed that patients with positive coexpression of either HOXC10/PDPK1 or HOXC10/VASP had the highest recurrence risk and lowest survival times in both HCC cohorts (Figure 4C-F, lower panel).